<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37730580</PMID><DateRevised><Year>2023</Year><Month>09</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2042-6410</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>20</Day></PubDate></JournalIssue><Title>Biology of sex differences</Title><ISOAbbreviation>Biol Sex Differ</ISOAbbreviation></Journal><ArticleTitle>Sex hormones and the risk of myocardial infarction in women and men: a prospective cohort study in the UK Biobank.</ArticleTitle><Pagination><StartPage>61</StartPage><MedlinePgn>61</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13293-023-00546-3</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">There is conflicting evidence around the role of sex hormones with cardiovascular outcomes. The aim of this study was to examine the association of sex hormones with the risk of myocardial infarction (MI) in pre- and post-menopausal women, and men in the UK Biobank.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The UK Biobank is a prospective population-based cohort study, that recruited over 500,000 (aged 40-69&#xa0;years) women and men between 2006 and 2010. Sex specific cox regression models, estimating hazard ratios (HRs) and women to men ratio of HRs (RHR) with respective 95% confidence intervals (CI), were used to model the association of sex hormones [oestrogen, testosterone, oestrogen: testosterone (O/T) ratio, sex hormone-binding globulin (SHBG) and the free androgen index (FAI)], measured at study baseline, with incident MI for women and men.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Data were from 479,797 participants [264,282 (55.1%) women] without a history of MI at study baseline. Over 12.5&#xa0;years of follow-up, there were 4,908 MI events in women and 10,517 in men. Neither oestrogen nor testosterone were associated with MI in women and men after multiple adjustment. For men, but not women, a unit higher log-transformed O/T ratio was associated with a lower risk of MI 0.79 (0.65, 0.95) after adjustment for traditional CVD risk factors. The corresponding women to men RHR (95% CI) was 1.24 (0.99, 1.56). Higher SHBG (per unit) was also associated with a lower risk of MI in men 0.94 (0.89, 0.99), and not in women 1.02 (0.95, 1.09) after multiple adjustment, the corresponding women to men RHR (95% CI) was 1.09 (1.00, 1.18). Higher FAI was associated with a higher risk of MI in men 1.09 (1.02, 1.15), though not in women 0.97 (0.92, 1.02), the corresponding women to men RHR was 0.89 (0.82, 0.97). Finally, there were differential effects in the association of SHBG and FAI between pre- and post-menopausal women.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">A higher O/T ratio was associated with a lower risk of MI, and a higher FAI with a higher risk of MI after adjustment for CVD risk factors in men, but not in women. Thus, hormone ratios, rather than each alone, may play an important role in modulating the effect of MI.</AbstractText><CopyrightInformation>&#xa9; 2023. Society for Women's Health Research and BioMed Central Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Harris</LastName><ForeName>Katie</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-2444-2869</Identifier><AffiliationInfo><Affiliation>The George Institute for Global Health, University of New South Wales, Level 5, 1 King St, Newtown, Sydney, NSW, 2042, Australia. kharris@georgeinstitute.org.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peters</LastName><ForeName>Sanne A E</ForeName><Initials>SAE</Initials><AffiliationInfo><Affiliation>The George Institute for Global Health, University of New South Wales, Level 5, 1 King St, Newtown, Sydney, NSW, 2042, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The George Institute for Global Health, Imperial College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Woodward</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The George Institute for Global Health, University of New South Wales, Level 5, 1 King St, Newtown, Sydney, NSW, 2042, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The George Institute for Global Health, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Biol Sex Differ</MedlineTA><NlmUniqueID>101548963</NlmUniqueID><ISSNLinking>2042-6410</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><OtherAbstract Type="plain-language-summary" Language="eng"><AbstractText>There are conflicting findings surrounding the association of sex hormones and myocardial infarction (MI) (heart disease). In particular, high oestradiol levels in women are often thought to be protective and explain why the rates of heart disease are lower in women than men. For men, those with low levels of testosterone are often thought to be more prone to develop heart disease in their lifetimes.Our study presents a comprehensive analysis of the association of sex hormones (in isolation and also together via their ratios), in women and men using the large-scale UK Biobank.We found that neither oestrogen nor testosterone alone were associated with heart disease in women and men after accounting for cardiovascular risk factors, but the ratio of testosterone and oestrogen was associated with a lower risk of heart disease in men, though not in women. We also saw the association of sex hormone&#x2013;binding globulin (SHBG), and free androgen index (FAI) (calculated by the ratio of total testosterone level to SHBG) with heart disease was different between women and men, and between pre- and post-menopausal women.This paper highlights the complex interplay between sex hormones with heart disease in the presence of age and cardiovascular risk factors. In particular the balance (ratio) of sex hormones maybe more important, rather than each in isolation, when exploring their association with heart disease.</AbstractText><CopyrightInformation>&#xa9; 2023. Society for Women's Health Research and BioMed Central Ltd.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Myocardial infarction</Keyword><Keyword MajorTopicYN="N">Sex hormones</Keyword><Keyword MajorTopicYN="N">UK Biobank</Keyword><Keyword MajorTopicYN="N">Women's health</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>21</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>21</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>20</Day><Hour>23</Hour><Minute>35</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37730580</ArticleId><ArticleId IdType="doi">10.1186/s13293-023-00546-3</ArticleId><ArticleId IdType="pii">10.1186/s13293-023-00546-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aribas E, Kavousi M, Laven JSE, Ikram MA, Roeters van Lennep JE. Aging, cardiovascular risk, and SHBG levels in men and women from the general population. J Clin Endocrinol Metab. 2021;106(10):2890&#x2013;900. https://doi.org/10.1210/clinem/dgab470 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgab470</ArticleId><ArticleId IdType="pubmed">34197576</ArticleId><ArticleId IdType="pmc">8475196</ArticleId></ArticleIdList></Reference><Reference><Citation>Batty GD, Gale CR, Kivimaki M, Deary IJ, Bell S. Comparison of risk factor associations in UK Biobank against representative, general population based studies with conventional response rates: prospective cohort study and individual participant meta-analysis. BMJ. 2020;368: m131. https://doi.org/10.1136/bmj.m131 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m131</ArticleId><ArticleId IdType="pubmed">32051121</ArticleId><ArticleId IdType="pmc">7190071</ArticleId></ArticleIdList></Reference><Reference><Citation>Bots SH, Peters SAE, Woodward M. Sex differences in coronary heart disease and stroke mortality: a global assessment of the effect of ageing between 1980 and 2010. BMJ Glob Health. 2017;2(2): e000298. https://doi.org/10.1136/bmjgh-2017-000298 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2017-000298</ArticleId><ArticleId IdType="pubmed">28589033</ArticleId><ArticleId IdType="pmc">5435266</ArticleId></ArticleIdList></Reference><Reference><Citation>Braunstein GD. Spurious serum hormone immunoassay results: causes, recognition, management. touchREV Endocrinol. 2022;18(2):141&#x2013;7. https://doi.org/10.17925/EE.2022.18.2.141 .</Citation><ArticleIdList><ArticleId IdType="doi">10.17925/EE.2022.18.2.141</ArticleId><ArticleId IdType="pubmed">36694886</ArticleId><ArticleId IdType="pmc">9835809</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai W, Li Y, Zheng H. Estradiol/testosterone imbalance: impact on coronary heart disease risk factors in postmenopausal women. Cardiology. 2012;121(4):249&#x2013;54. https://doi.org/10.1159/000337274 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000337274</ArticleId><ArticleId IdType="pubmed">22572464</ArticleId></ArticleIdList></Reference><Reference><Citation>Dam V, Onland-Moret NC, Burgess S, Chirlaque MD, Peters SAE, Schuit E, Tikk K, Weiderpass E, Oliver-Williams C, Wood AM, Tjonneland A, Dahm CC, Overvad K, Boutron-Ruault MC, Schulze MB, Trichopoulou A, Ferrari P, Masala G, Krogh V, van der Schouw YT. Genetically determined reproductive aging and coronary heart disease: a bidirectional 2-sample mendelian randomization. J Clin Endocrinol Metab. 2022;107(7):e2952&#x2013;61. https://doi.org/10.1210/clinem/dgac171 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgac171</ArticleId><ArticleId IdType="pubmed">35306566</ArticleId><ArticleId IdType="pmc">9202700</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis SR, Wahlin-Jacobsen S. Testosterone in women&#x2013;the clinical significance. Lancet Diabetes Endocrinol. 2015;3(12):980&#x2013;92. https://doi.org/10.1016/S2213-8587(15)00284-3 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(15)00284-3</ArticleId><ArticleId IdType="pubmed">26358173</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrzycki S, Serwatka W, Nadlewski S, Korecki J, Jackowski R, Paruk J, Ladny JR, Hirnle T. An assessment of correlations between endogenous sex hormone levels and the extensiveness of coronary heart disease and the ejection fraction of the left ventricle in males. J Med Invest. 2003;50(3&#x2013;4):162&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">13678385</ArticleId></ArticleIdList></Reference><Reference><Citation>El Khoudary SR, Aggarwal B, Beckie TM, Hodis HN, Johnson AE, Langer RD, Limacher MC, Manson JE, Stefanick ML, Allison MA, American Heart Association Prevention Science Committee of the Council on, E., Prevention, Council on, C., &amp; Stroke, N. Menopause transition and cardiovascular disease risk: implications for timing of early prevention: a scientific statement from the American heart association. Circulation. 2020;142(25):e506&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000912</ArticleId><ArticleId IdType="pubmed">33251828</ArticleId></ArticleIdList></Reference><Reference><Citation>English KM, Mandour O, Steeds RP, Diver MJ, Jones TH, Channer KS. Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms. Eur Heart J. 2000;21(11):890&#x2013;4. https://doi.org/10.1053/euhj.1999.1873 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/euhj.1999.1873</ArticleId><ArticleId IdType="pubmed">10806012</ArticleId></ArticleIdList></Reference><Reference><Citation>Escobar-Morreale HF, Alvarez-Blasco F, Botella-Carretero JI, Luque-Ramirez M. The striking similarities in the metabolic associations of female androgen excess and male androgen deficiency. Hum Reprod. 2014;29(10):2083&#x2013;91. https://doi.org/10.1093/humrep/deu198 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/humrep/deu198</ArticleId><ArticleId IdType="pubmed">25104855</ArticleId></ArticleIdList></Reference><Reference><Citation>Fry A, Littlejohns TJ, Sudlow C, Doherty N, Adamska L, Sprosen T, Collins R, Allen NE. Comparison of sociodemographic and health-related characteristics of UK Biobank participants with those of the general population. Am J Epidemiol. 2017;186(9):1026&#x2013;34. https://doi.org/10.1093/aje/kwx246 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwx246</ArticleId><ArticleId IdType="pubmed">28641372</ArticleId><ArticleId IdType="pmc">5860371</ArticleId></ArticleIdList></Reference><Reference><Citation>Institute for health metrics and evaluation. GBD compare data visualization. 2019. http://vizhub.healthdata.org/gbd-compare . Accessed 1 Aug 2023</Citation></Reference><Reference><Citation>Iorga A, Cunningham CM, Moazeni S, Ruffenach G, Umar S, Eghbali M. The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy. Biol Sex Differ. 2017;8(1):33. https://doi.org/10.1186/s13293-017-0152-8 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13293-017-0152-8</ArticleId><ArticleId IdType="pubmed">29065927</ArticleId><ArticleId IdType="pmc">5655818</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam RM, Bell RJ, Handelsman DJ, McNeil JJ, Nelson MR, Reid CM, Tonkin AM, Wolfe RS, Woods RL, Davis SR. Associations between blood sex steroid concentrations and risk of major adverse cardiovascular events in healthy older women in Australia: a prospective cohort substudy of the ASPREE trial. Lancet Healthy Longev. 2022;3(2):e109&#x2013;18. https://doi.org/10.1016/S2666-7568(22)00001-0 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-7568(22)00001-0</ArticleId><ArticleId IdType="pubmed">35252940</ArticleId><ArticleId IdType="pmc">8896500</ArticleId></ArticleIdList></Reference><Reference><Citation>Klaiber EL, Broverman DM, Haffajee CI, Hochman JS, Sacks GM, Dalen JE. Serum estrogen levels in men with acute myocardial infarction. Am J Med. 1982;73(6):872&#x2013;81. https://doi.org/10.1016/0002-9343(82)90779-3 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9343(82)90779-3</ArticleId><ArticleId IdType="pubmed">7148879</ArticleId></ArticleIdList></Reference><Reference><Citation>Kloner RA, Carson C 3rd, Dobs A, Kopecky S, Mohler ER 3rd. Testosterone and cardiovascular disease. J Am Coll Cardiol. 2016;67(5):545&#x2013;57. https://doi.org/10.1016/j.jacc.2015.12.005 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2015.12.005</ArticleId><ArticleId IdType="pubmed">26846952</ArticleId></ArticleIdList></Reference><Reference><Citation>Legro RS. Polycystic ovary syndrome and cardiovascular disease: a premature association? Endocr Rev. 2003;24(3):302&#x2013;12. https://doi.org/10.1210/er.2003-0004 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/er.2003-0004</ArticleId><ArticleId IdType="pubmed">12788801</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo S, Au Yeung SL, Zhao JV, Burgess S, Schooling CM. Association of genetically predicted testosterone with thromboembolism, heart failure, and myocardial infarction: mendelian randomisation study in UK Biobank. BMJ. 2019;364:l476. https://doi.org/10.1136/bmj.l476 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l476</ArticleId><ArticleId IdType="pubmed">30842065</ArticleId><ArticleId IdType="pmc">6402044</ArticleId></ArticleIdList></Reference><Reference><Citation>Maas AH, Appelman YE. Gender differences in coronary heart disease. Neth Heart J. 2010;18(12):598&#x2013;602. https://doi.org/10.1007/s12471-010-0841-y .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12471-010-0841-y</ArticleId><ArticleId IdType="pubmed">21301622</ArticleId><ArticleId IdType="pmc">3018605</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamad MJ, Mohammad MA, Karayyem M, Hairi A, Hader AA. Serum levels of sex hormones in men with acute myocardial infarction. Neuro Endocrinol Lett. 2007;28(2):182&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">17435665</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutz J, Roscoe CJ, Lewis CM. Exploring health in the UK Biobank: associations with sociodemographic characteristics, psychosocial factors, lifestyle and environmental exposures. BMC Med. 2021;19(1):240. https://doi.org/10.1186/s12916-021-02097-z .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02097-z</ArticleId><ArticleId IdType="pubmed">34629060</ArticleId><ArticleId IdType="pmc">8504077</ArticleId></ArticleIdList></Reference><Reference><Citation>Oskui PM, French WJ, Herring MJ, Mayeda GS, Burstein S, Kloner RA. Testosterone and the cardiovascular system: a comprehensive review of the clinical literature. J Am Heart Assoc. 2013;2(6): e000272. https://doi.org/10.1161/JAHA.113.000272 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.113.000272</ArticleId><ArticleId IdType="pubmed">24242682</ArticleId><ArticleId IdType="pmc">3886770</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters SAE, Woodward M. Oestradiol and the risk of myocardial infarction in women: a cohort study of UK Biobank participants. Int J Epidemiol. 2021;50(4):1241&#x2013;9. https://doi.org/10.1093/ije/dyaa284 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyaa284</ArticleId><ArticleId IdType="pubmed">33734370</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips GB, Castelli WP, Abbott RD, McNamara PM. Association of hyperestrogenemia and coronary heart disease in men in the Framingham cohort. Am J Med. 1983;74(5):863&#x2013;9. https://doi.org/10.1016/0002-9343(83)91078-1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9343(83)91078-1</ArticleId><ArticleId IdType="pubmed">6837609</ArticleId></ArticleIdList></Reference><Reference><Citation>Scarabin PY. Endogenous sex hormones and cardiovascular disease in postmenopausal women: new but conflicting data. Ann Transl Med. 2018;6(23):448. https://doi.org/10.21037/atm.2018.11.18 .</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm.2018.11.18</ArticleId><ArticleId IdType="pubmed">30603636</ArticleId><ArticleId IdType="pmc">6312811</ArticleId></ArticleIdList></Reference><Reference><Citation>Schederecker F, Cecil A, Prehn C, Nano J, Koenig W, Adamski J, Zeller T, Peters A, Thorand B. Sex hormone-binding globulin, androgens and mortality: the KORA-F4 cohort study. Endocr Connect. 2020;9(4):326&#x2013;36. https://doi.org/10.1530/EC-20-0080 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EC-20-0080</ArticleId><ArticleId IdType="pubmed">32168474</ArticleId><ArticleId IdType="pmc">7219137</ArticleId></ArticleIdList></Reference><Reference><Citation>Sievers C, Klotsche J, Pieper L, Schneider HJ, Marz W, Wittchen HU, Stalla GK, Mantzoros C. Low testosterone levels predict all-cause mortality and cardiovascular events in women: a prospective cohort study in German primary care patients. Eur J Endocrinol. 2010;163(4):699&#x2013;708. https://doi.org/10.1530/EJE-10-0307 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EJE-10-0307</ArticleId><ArticleId IdType="pubmed">20685832</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutton-Tyrrell K, Wildman RP, Matthews KA, Chae C, Lasley BL, Brockwell S, Pasternak RC, Lloyd-Jones D, Sowers MF, Torrens JI, Investigators S. Sex-hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN). Circulation. 2005;111(10):1242&#x2013;9. https://doi.org/10.1161/01.CIR.0000157697.54255.CE .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000157697.54255.CE</ArticleId><ArticleId IdType="pubmed">15769764</ArticleId></ArticleIdList></Reference><Reference><Citation>Wild RA, Carmina E, Diamanti-Kandarakis E, Dokras A, Escobar-Morreale HF, Futterweit W, Lobo R, Norman RJ, Talbott E, Dumesic DA. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab. 2010;95(5):2038&#x2013;49. https://doi.org/10.1210/jc.2009-2724 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2009-2724</ArticleId><ArticleId IdType="pubmed">20375205</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodward M. Rationale and tutorial for analysing and reporting sex differences in cardiovascular associations. Heart. 2019;105(22):1701&#x2013;8. https://doi.org/10.1136/heartjnl-2019-315299 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2019-315299</ArticleId><ArticleId IdType="pubmed">31371439</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeap BB, Marriott RJ, Antonio L, Raj S, Dwivedi G, Reid CM, Anawalt BD, Bhasin S, Dobs AS, Handelsman DJ, Hankey GJ, Haring R, Matsumoto AM, Norman PE, O&#x2019;Neill TW, Ohlsson C, Orwoll ES, Vanderschueren D, Wittert GA, Murray K. Associations of serum testosterone and sex hormone-binding globulin with incident cardiovascular events in middle-aged to older men. Ann Intern Med. 2022;175(2):159&#x2013;70. https://doi.org/10.7326/M21-0551 .</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M21-0551</ArticleId><ArticleId IdType="pubmed">34958606</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao D, Guallar E, Michos ED. Reply: free androgen index as a biomarker of increased cardiovascular risk in postmenopausal women. J Am Coll Cardiol. 2018;72(16):1987. https://doi.org/10.1016/j.jacc.2018.08.1042 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.08.1042</ArticleId><ArticleId IdType="pubmed">30309480</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao D, Guallar E, Ouyang P, Subramanya V, Vaidya D, Ndumele CE, Lima JA, Allison MA, Shah SJ, Bertoni AG, Budoff MJ, Post WS, Michos ED. Endogenous sex hormones and incident cardiovascular disease in post-menopausal women. J Am Coll Cardiol. 2018;71(22):2555&#x2013;66. https://doi.org/10.1016/j.jacc.2018.01.083 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.01.083</ArticleId><ArticleId IdType="pubmed">29852978</ArticleId><ArticleId IdType="pmc">5986086</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao JV, Schooling CM. Genetically predicted sex hormone binding globulin and ischemic heart disease in men and women: a univariable and multivariable Mendelian randomization study. Sci Rep. 2021;11(1):23172. https://doi.org/10.1038/s41598-021-02510-w .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-02510-w</ArticleId><ArticleId IdType="pubmed">34848757</ArticleId><ArticleId IdType="pmc">8632960</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>